fanta.bio Sample: CNhs11327
12819 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 888 / 5814 (15.3%) | 184 / 58140 (0.3%) | −324.0 | −324.0 | 48.26 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1255 / 5814 (21.6%) | 305 / 58140 (0.5%) | −324.0 | −324.0 | 41.15 |
| HIF1A SRX11007095 | HK-2 Kidney | 980 / 5814 (16.9%) | 453 / 58140 (0.8%) | −324.0 | −324.0 | 21.63 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 739 / 5814 (12.7%) | 364 / 58140 (0.6%) | −324.0 | −324.0 | 20.30 |
| SCML2 SRX644728 | 293 Kidney | 667 / 5814 (11.5%) | 350 / 58140 (0.6%) | −324.0 | −324.0 | 19.06 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 999 / 5814 (17.2%) | 538 / 58140 (0.9%) | −324.0 | −324.0 | 18.57 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1015 / 5814 (17.5%) | 561 / 58140 (1.0%) | −324.0 | −324.0 | 18.09 |
| MED1 SRX9419944 | BT-474 Breast | 1525 / 5814 (26.2%) | 1264 / 58140 (2.2%) | −324.0 | −324.0 | 12.06 |
| MED1 SRX9419945 | BT-474 Breast | 1544 / 5814 (26.6%) | 1287 / 58140 (2.2%) | −324.0 | −324.0 | 12.00 |
| BRD4 SRX9419936 | BT-474 Breast | 1564 / 5814 (26.9%) | 1334 / 58140 (2.3%) | −324.0 | −324.0 | 11.72 |
| MED1 SRX9419947 | BT-474 Breast | 1528 / 5814 (26.3%) | 1316 / 58140 (2.3%) | −324.0 | −324.0 | 11.61 |
| FOXP1 SRX736067 | LNCAP Prostate | 620 / 5814 (10.7%) | 536 / 58140 (0.9%) | −324.0 | −324.0 | 11.57 |
| BRD4 SRX9419938 | BT-474 Breast | 1520 / 5814 (26.1%) | 1321 / 58140 (2.3%) | −324.0 | −324.0 | 11.51 |
| MED1 SRX9419946 | BT-474 Breast | 1551 / 5814 (26.7%) | 1350 / 58140 (2.3%) | −324.0 | −324.0 | 11.49 |
| BRD4 SRX9419935 | BT-474 Breast | 1487 / 5814 (25.6%) | 1299 / 58140 (2.2%) | −324.0 | −324.0 | 11.45 |
| BRD4 SRX9419937 | BT-474 Breast | 1490 / 5814 (25.6%) | 1315 / 58140 (2.3%) | −324.0 | −324.0 | 11.33 |
| BRD4 SRX736201 | 90-8TL Neural | 2551 / 5814 (43.9%) | 2628 / 58140 (4.5%) | −324.0 | −324.0 | 9.71 |
| EZH2 SRX2146136 | LNCAP Prostate | 3084 / 5814 (53.0%) | 3352 / 58140 (5.8%) | −324.0 | −324.0 | 9.20 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 742 / 5814 (12.8%) | 1099 / 58140 (1.9%) | −295.2 | −291.9 | 6.75 |
| 5-mC SRX882970 | LNCAP Prostate | 1533 / 5814 (26.4%) | 5338 / 58140 (9.2%) | −275.2 | −272.0 | 2.87 |
| 5-mC SRX882968 | LNCAP Prostate | 1518 / 5814 (26.1%) | 5300 / 58140 (9.1%) | −271.0 | −267.8 | 2.86 |
| RUNX1 SRX2513054 | 293 Kidney | 1637 / 5814 (28.2%) | 6332 / 58140 (10.9%) | −252.4 | −249.2 | 2.59 |
| 5-mC SRX882965 | LNCAP Prostate | 1274 / 5814 (21.9%) | 4179 / 58140 (7.2%) | −242.5 | −239.3 | 3.05 |
| AGO2 SRX4708039 | Hep G2 Liver | 978 / 5814 (16.8%) | 2679 / 58140 (4.6%) | −227.6 | −224.5 | 3.65 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 397 / 5814 (6.8%) | 362 / 58140 (0.6%) | −206.3 | −203.2 | 10.97 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1061 / 5814 (18.2%) | 3496 / 58140 (6.0%) | −196.5 | −193.4 | 3.03 |
| CIC SRX13262055 | Astrocytes Neural | 1440 / 5814 (24.8%) | 5965 / 58140 (10.3%) | −192.5 | −189.4 | 2.41 |
| TRP47 SRX4548329 | THP-1 Blood | 1265 / 5814 (21.8%) | 4983 / 58140 (8.6%) | −181.3 | −178.2 | 2.54 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 253 / 5814 (4.4%) | 99 / 58140 (0.2%) | −180.1 | −177.0 | 25.56 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 734 / 5814 (12.6%) | 1900 / 58140 (3.3%) | −178.6 | −175.5 | 3.86 |
| Epitope tags SRX10549776 | K-562 Blood | 713 / 5814 (12.3%) | 1906 / 58140 (3.3%) | −167.0 | −164.0 | 3.74 |
| TP53 SRX19538279 | Osteoblasts Bone | 249 / 5814 (4.3%) | 119 / 58140 (0.2%) | −166.9 | −163.9 | 20.92 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 303 / 5814 (5.2%) | 245 / 58140 (0.4%) | −166.2 | −163.2 | 12.37 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 864 / 5814 (14.9%) | 2812 / 58140 (4.8%) | −159.9 | −156.9 | 3.07 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 293 / 5814 (5.0%) | 253 / 58140 (0.4%) | −155.8 | −152.8 | 11.58 |
| SREBF2 SRX5359048 | HCC70 Breast | 829 / 5814 (14.3%) | 2729 / 58140 (4.7%) | −150.5 | −147.5 | 3.04 |
| BRD4 SRX736204 | 90-8TL Neural | 487 / 5814 (8.4%) | 976 / 58140 (1.7%) | −150.3 | −147.3 | 4.99 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 887 / 5814 (15.3%) | 3085 / 58140 (5.3%) | −149.4 | −146.4 | 2.88 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 811 / 5814 (13.9%) | 2647 / 58140 (4.6%) | −148.8 | −145.8 | 3.06 |
| MITF SRX1555436 | 501A Epidermis | 939 / 5814 (16.2%) | 3416 / 58140 (5.9%) | −148.3 | −145.4 | 2.75 |
| MYH11 SRX265221 | ME-1 Blood | 299 / 5814 (5.1%) | 304 / 58140 (0.5%) | −146.4 | −143.5 | 9.84 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 574 / 5814 (9.9%) | 1413 / 58140 (2.4%) | −145.8 | −142.9 | 4.06 |
| TP53 SRX19538274 | U2OS Bone | 203 / 5814 (3.5%) | 78 / 58140 (0.1%) | −145.1 | −142.2 | 26.03 |
| TP53 SRX19538280 | Osteoblasts Bone | 210 / 5814 (3.6%) | 97 / 58140 (0.2%) | −142.2 | −139.3 | 21.65 |
| TP53 SRX19538268 | U2OS Bone | 205 / 5814 (3.5%) | 91 / 58140 (0.2%) | −140.5 | −137.7 | 22.53 |
| AGO2 SRX6783958 | Hep G2 Liver | 594 / 5814 (10.2%) | 1575 / 58140 (2.7%) | −139.2 | −136.3 | 3.77 |
| BMI1 SRX7196721 | SF8628 Neural | 823 / 5814 (14.2%) | 2854 / 58140 (4.9%) | −138.4 | −135.5 | 2.88 |
| IRF3 SRX11453858 | Hep G2 Liver | 173 / 5814 (3.0%) | 42 / 58140 (0.1%) | −137.9 | −135.1 | 41.19 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 306 / 5814 (5.3%) | 363 / 58140 (0.6%) | −137.3 | −134.5 | 8.43 |
| AGO2 SRX6783957 | Hep G2 Liver | 597 / 5814 (10.3%) | 1611 / 58140 (2.8%) | −137.1 | −134.3 | 3.71 |
| TP53 SRX19538275 | U2OS Bone | 192 / 5814 (3.3%) | 75 / 58140 (0.1%) | −136.6 | −133.8 | 25.60 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 896 / 5814 (15.4%) | 3345 / 58140 (5.8%) | −135.1 | −132.3 | 2.68 |
| TP53 SRX19538276 | U2OS Bone | 195 / 5814 (3.4%) | 84 / 58140 (0.1%) | −134.9 | −132.1 | 23.21 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 884 / 5814 (15.2%) | 3288 / 58140 (5.7%) | −134.1 | −131.3 | 2.69 |
| MECOM SRX23677884 | HNT-34 Blood | 826 / 5814 (14.2%) | 2953 / 58140 (5.1%) | −132.5 | −129.8 | 2.80 |
| RUNX1 SRX2014504 | Jurkat Blood | 1084 / 5814 (18.6%) | 4617 / 58140 (7.9%) | −132.1 | −129.3 | 2.35 |
| MECOM SRX23677897 | HNT-34 Blood | 939 / 5814 (16.2%) | 3686 / 58140 (6.3%) | −130.8 | −128.0 | 2.55 |
| PBX4 SRX2731658 | PC-3 Prostate | 289 / 5814 (5.0%) | 9020 / 58140 (15.5%) | −130.7 | −127.9 | 0.32 |
| TP53 SRX19538269 | U2OS Bone | 230 / 5814 (4.0%) | 172 / 58140 (0.3%) | −130.4 | −127.6 | 13.37 |
| YAP1 SRX757325 | H2052 Lung | 173 / 5814 (3.0%) | 7070 / 58140 (12.2%) | −129.8 | −127.1 | 0.24 |
| MECOM SRX23677896 | HNT-34 Blood | 959 / 5814 (16.5%) | 3830 / 58140 (6.6%) | −129.8 | −127.0 | 2.50 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 828 / 5814 (14.2%) | 3020 / 58140 (5.2%) | −128.8 | −126.0 | 2.74 |
| PTEN SRX5416007 | SMMC-7721 Liver | 828 / 5814 (14.2%) | 3058 / 58140 (5.3%) | −126.3 | −123.6 | 2.71 |
| MECOM SRX23677885 | HNT-34 Blood | 816 / 5814 (14.0%) | 2986 / 58140 (5.1%) | −126.2 | −123.5 | 2.73 |
| TP53 SRX19538270 | U2OS Bone | 220 / 5814 (3.8%) | 163 / 58140 (0.3%) | −125.2 | −122.5 | 13.50 |
| TP53 SRX19538281 | Osteoblasts Bone | 206 / 5814 (3.5%) | 131 / 58140 (0.2%) | −124.8 | −122.1 | 15.73 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 644 / 5814 (11.1%) | 2001 / 58140 (3.4%) | −124.6 | −121.9 | 3.22 |
| AR SRX10820653 | LNCAP Prostate | 186 / 5814 (3.2%) | 89 / 58140 (0.2%) | −124.5 | −121.8 | 20.90 |
| TP53 SRX19538273 | U2OS Bone | 178 / 5814 (3.1%) | 74 / 58140 (0.1%) | −124.4 | −121.7 | 24.05 |
| YAP1 SRX757326 | H2052 Lung | 139 / 5814 (2.4%) | 6287 / 58140 (10.8%) | −123.7 | −121.0 | 0.22 |
| TP53 SRX19538267 | U2OS Bone | 177 / 5814 (3.0%) | 74 / 58140 (0.1%) | −123.5 | −120.8 | 23.92 |
| TET2 SRX2014505 | Jurkat Blood | 1151 / 5814 (19.8%) | 5250 / 58140 (9.0%) | −123.1 | −120.5 | 2.19 |
| CDYL2 SRX8321653 | MCF-7 Breast | 826 / 5814 (14.2%) | 3134 / 58140 (5.4%) | −120.4 | −117.8 | 2.64 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 718 / 5814 (12.3%) | 2518 / 58140 (4.3%) | −117.6 | −115.0 | 2.85 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 283 / 5814 (4.9%) | 382 / 58140 (0.7%) | −117.1 | −114.4 | 7.41 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 840 / 5814 (14.4%) | 3281 / 58140 (5.6%) | −116.9 | −114.2 | 2.56 |
| IRF3 SRX11453861 | Hep G2 Liver | 149 / 5814 (2.6%) | 43 / 58140 (0.1%) | −114.5 | −111.8 | 34.65 |
| AR SRX10820651 | LNCAP Prostate | 184 / 5814 (3.2%) | 113 / 58140 (0.2%) | −112.9 | −110.3 | 16.28 |
| ERG SRX063922 | K-562 Blood | 710 / 5814 (12.2%) | 2553 / 58140 (4.4%) | −111.8 | −109.2 | 2.78 |
| RORC SRX5359052 | HCC70 Breast | 592 / 5814 (10.2%) | 1883 / 58140 (3.2%) | −110.5 | −107.9 | 3.14 |
| TP53 SRX19538271 | U2OS Bone | 287 / 5814 (4.9%) | 431 / 58140 (0.7%) | −110.4 | −107.8 | 6.66 |
| TP53 SRX19538282 | Osteoblasts Bone | 183 / 5814 (3.1%) | 121 / 58140 (0.2%) | −109.1 | −106.5 | 15.12 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 893 / 5814 (15.4%) | 3758 / 58140 (6.5%) | −109.1 | −106.5 | 2.38 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 372 / 5814 (6.4%) | 807 / 58140 (1.4%) | −106.0 | −103.4 | 4.61 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 148 / 5814 (2.5%) | 57 / 58140 (0.1%) | −105.7 | −103.2 | 25.96 |
| ERG SRX063921 | K-562 Blood | 662 / 5814 (11.4%) | 2371 / 58140 (4.1%) | −104.5 | −101.9 | 2.79 |
| Epitope tags SRX2255894 | 293 Kidney | 596 / 5814 (10.3%) | 1986 / 58140 (3.4%) | −104.1 | −101.5 | 3.00 |
| GATA3 SRX190194 | SK-N-SH Neural | 195 / 5814 (3.4%) | 6629 / 58140 (11.4%) | −102.2 | −99.6 | 0.29 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 192 / 5814 (3.3%) | 6575 / 58140 (11.3%) | −102.1 | −99.5 | 0.29 |
| MethylCap SRX014767 | NB-4 Blood | 729 / 5814 (12.5%) | 2854 / 58140 (4.9%) | −99.9 | −97.4 | 2.55 |
| RORC SRX5359053 | HCC70 Breast | 556 / 5814 (9.6%) | 1815 / 58140 (3.1%) | −99.7 | −97.1 | 3.06 |
| KAT7 SRX101303 | RKO Digestive tract | 557 / 5814 (9.6%) | 1853 / 58140 (3.2%) | −97.4 | −94.8 | 3.01 |
| BRPF3 SRX796085 | RKO Digestive tract | 463 / 5814 (8.0%) | 1338 / 58140 (2.3%) | −97.1 | −94.5 | 3.46 |
| TP53 SRX19538272 | U2OS Bone | 256 / 5814 (4.4%) | 396 / 58140 (0.7%) | −96.3 | −93.8 | 6.46 |
| LARP7 SRX2198835 | HeLa Uterus | 868 / 5814 (14.9%) | 3830 / 58140 (6.6%) | −96.3 | −93.7 | 2.27 |
| SS18 SRX3468047 | Fibroblasts Others | 219 / 5814 (3.8%) | 6811 / 58140 (11.7%) | −95.6 | −93.1 | 0.32 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 284 / 5814 (4.9%) | 511 / 58140 (0.9%) | −95.2 | −92.7 | 5.56 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 162 / 5814 (2.8%) | 5860 / 58140 (10.1%) | −95.2 | −92.6 | 0.28 |
| CTCF SRX10975999 | NALM-6 Blood | 1242 / 5814 (21.4%) | 6584 / 58140 (11.3%) | −93.9 | −91.4 | 1.89 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 717 / 5814 (12.3%) | 2886 / 58140 (5.0%) | −93.6 | −91.0 | 2.48 |
| ZFX SRX7805372 | 293 Kidney | 656 / 5814 (11.3%) | 2503 / 58140 (4.3%) | −93.4 | −90.9 | 2.62 |
| JUN SRX17561461 | LPS141 Adipocyte | 113 / 5814 (1.9%) | 4909 / 58140 (8.4%) | −92.3 | −89.8 | 0.23 |
| CTCF SRX12008351 | MCF 10A Breast | 1150 / 5814 (19.8%) | 5936 / 58140 (10.2%) | −92.3 | −89.8 | 1.94 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 236 / 5814 (4.1%) | 350 / 58140 (0.6%) | −91.5 | −89.0 | 6.74 |
| SREBF2 SRX5359049 | HCC70 Breast | 523 / 5814 (9.0%) | 1738 / 58140 (3.0%) | −91.4 | −88.9 | 3.01 |
| BRD1 SRX286203 | RKO Digestive tract | 488 / 5814 (8.4%) | 1548 / 58140 (2.7%) | −90.8 | −88.3 | 3.15 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 324 / 5814 (5.6%) | 8244 / 58140 (14.2%) | −90.5 | −88.0 | 0.39 |
| Epitope tags SRX2867680 | 293 Kidney | 842 / 5814 (14.5%) | 3772 / 58140 (6.5%) | −90.3 | −87.9 | 2.23 |
| FOXL2 SRX6957431 | KGN Gonad | 203 / 5814 (3.5%) | 6382 / 58140 (11.0%) | −90.2 | −87.7 | 0.32 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 770 / 5814 (13.2%) | 3293 / 58140 (5.7%) | −90.0 | −87.5 | 2.34 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 222 / 5814 (3.8%) | 6671 / 58140 (11.5%) | −89.7 | −87.2 | 0.33 |
| HIF1A SRX20663235 | HK-2 Kidney | 165 / 5814 (2.8%) | 136 / 58140 (0.2%) | −89.5 | −87.1 | 12.13 |
| BRPF3 SRX796084 | RKO Digestive tract | 603 / 5814 (10.4%) | 2238 / 58140 (3.8%) | −89.5 | −87.0 | 2.69 |
| SMARCA2 SRX8119677 | MeT-5A Others | 139 / 5814 (2.4%) | 5255 / 58140 (9.0%) | −88.3 | −85.9 | 0.26 |
| MECOM SRX23677890 | HNT-34 Blood | 741 / 5814 (12.7%) | 3136 / 58140 (5.4%) | −88.3 | −85.8 | 2.36 |
| MethylCap SRX014766 | NB-4 Blood | 643 / 5814 (11.1%) | 2505 / 58140 (4.3%) | −88.1 | −85.7 | 2.57 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 689 / 5814 (11.9%) | 2807 / 58140 (4.8%) | −87.7 | −85.3 | 2.45 |
| BRPF3 SRX796086 | RKO Digestive tract | 575 / 5814 (9.9%) | 2109 / 58140 (3.6%) | −86.8 | −84.3 | 2.73 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 333 / 5814 (5.7%) | 8202 / 58140 (14.1%) | −85.7 | −83.2 | 0.41 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 107 / 5814 (1.8%) | 4603 / 58140 (7.9%) | −85.6 | −83.2 | 0.23 |
| MECOM SRX23677891 | HNT-34 Blood | 735 / 5814 (12.6%) | 3146 / 58140 (5.4%) | −85.6 | −83.1 | 2.34 |
| EP300 SRX2671813 | Fibroblasts Others | 52 / 5814 (0.9%) | 3500 / 58140 (6.0%) | −85.2 | −82.8 | 0.15 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 221 / 5814 (3.8%) | 6495 / 58140 (11.2%) | −84.9 | −82.5 | 0.34 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 201 / 5814 (3.5%) | 6159 / 58140 (10.6%) | −84.3 | −81.9 | 0.33 |
| BMI1 SRX644729 | 293 Kidney | 124 / 5814 (2.1%) | 57 / 58140 (0.1%) | −84.2 | −81.7 | 21.75 |
| CTCF SRX12008350 | MCF 10A Breast | 1147 / 5814 (19.7%) | 6132 / 58140 (10.5%) | −83.8 | −81.4 | 1.87 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 128 / 5814 (2.2%) | 4926 / 58140 (8.5%) | −83.7 | −81.3 | 0.26 |
| RBFOX2 SRX4708082 | K-562 Blood | 916 / 5814 (15.8%) | 4432 / 58140 (7.6%) | −83.7 | −81.3 | 2.07 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 243 / 5814 (4.2%) | 6798 / 58140 (11.7%) | −83.7 | −81.2 | 0.36 |
| Epitope tags SRX10549778 | K-562 Blood | 465 / 5814 (8.0%) | 1531 / 58140 (2.6%) | −82.0 | −79.6 | 3.04 |
| CHD6 SRX17709201 | C4-2 Prostate | 623 / 5814 (10.7%) | 2487 / 58140 (4.3%) | −81.7 | −79.3 | 2.51 |
| GRHL3 SRX2582162 | NHEK Epidermis | 448 / 5814 (7.7%) | 1440 / 58140 (2.5%) | −81.6 | −79.2 | 3.11 |
| SSRP1 SRX3436567 | HT-1080 Bone | 181 / 5814 (3.1%) | 214 / 58140 (0.4%) | −81.3 | −78.9 | 8.46 |
| NR3C1 SRX2609664 | HASM2 Lung | 127 / 5814 (2.2%) | 4816 / 58140 (8.3%) | −80.7 | −78.3 | 0.26 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 80 / 5814 (1.4%) | 3941 / 58140 (6.8%) | −80.5 | −78.1 | 0.20 |
| STAT5B SRX831881 | CD8+ T cells Blood | 127 / 5814 (2.2%) | 72 / 58140 (0.1%) | −80.4 | −78.0 | 17.64 |
| JUN SRX6582171 | GM07492 Others | 186 / 5814 (3.2%) | 5780 / 58140 (9.9%) | −80.0 | −77.7 | 0.32 |
| TCF12 SRX190356 | SK-N-SH Neural | 277 / 5814 (4.8%) | 7160 / 58140 (12.3%) | −79.4 | −77.0 | 0.39 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 573 / 5814 (9.9%) | 2214 / 58140 (3.8%) | −79.2 | −76.8 | 2.59 |
| CHD6 SRX17709200 | C4-2 Prostate | 633 / 5814 (10.9%) | 2602 / 58140 (4.5%) | −78.9 | −76.5 | 2.43 |
| Epitope tags SRX10549777 | K-562 Blood | 934 / 5814 (16.1%) | 4676 / 58140 (8.0%) | −78.9 | −76.5 | 2.00 |
| NR3C1 SRX2609659 | HASM2 Lung | 103 / 5814 (1.8%) | 4324 / 58140 (7.4%) | −78.7 | −76.3 | 0.24 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 333 / 5814 (5.7%) | 7938 / 58140 (13.7%) | −78.4 | −76.0 | 0.42 |
| NR3C1 SRX2609666 | HASM2 Lung | 79 / 5814 (1.4%) | 3859 / 58140 (6.6%) | −78.2 | −75.8 | 0.20 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 140 / 5814 (2.4%) | 4960 / 58140 (8.5%) | −78.1 | −75.8 | 0.28 |
| RELA SRX2207673 | HUVEC Cardiovascular | 392 / 5814 (6.7%) | 8741 / 58140 (15.0%) | −77.6 | −75.3 | 0.45 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 263 / 5814 (4.5%) | 550 / 58140 (0.9%) | −77.3 | −75.0 | 4.78 |
| FOXA1 SRX4815197 | MCF-7 Breast | 249 / 5814 (4.3%) | 6671 / 58140 (11.5%) | −77.3 | −75.0 | 0.37 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 236 / 5814 (4.1%) | 437 / 58140 (0.8%) | −77.2 | −74.8 | 5.40 |
| FOXA1 SRX4815198 | MCF-7 Breast | 352 / 5814 (6.1%) | 8153 / 58140 (14.0%) | −76.9 | −74.5 | 0.43 |
| RELA SRX2207672 | HUVEC Cardiovascular | 421 / 5814 (7.2%) | 9098 / 58140 (15.6%) | −76.6 | −74.2 | 0.46 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 115 / 5814 (2.0%) | 4471 / 58140 (7.7%) | −76.5 | −74.1 | 0.26 |
| KLF4 SRX12144701 | T/C28a2 Bone | 1040 / 5814 (17.9%) | 5534 / 58140 (9.5%) | −76.0 | −73.7 | 1.88 |
| YAP1 SRX1038945 | IMR-90 Lung | 54 / 5814 (0.9%) | 3286 / 58140 (5.7%) | −75.8 | −73.5 | 0.16 |
| JUN SRX6582172 | Fibroblasts Others | 123 / 5814 (2.1%) | 4591 / 58140 (7.9%) | −75.8 | −73.4 | 0.27 |
| JUNB SRX8488074 | SUM 229PE Breast | 128 / 5814 (2.2%) | 4676 / 58140 (8.0%) | −75.7 | −73.4 | 0.27 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 303 / 5814 (5.2%) | 7396 / 58140 (12.7%) | −75.4 | −73.1 | 0.41 |
| GRHL3 SRX2582161 | NHEK Epidermis | 382 / 5814 (6.6%) | 1157 / 58140 (2.0%) | −75.1 | −72.8 | 3.30 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 621 / 5814 (10.7%) | 2596 / 58140 (4.5%) | −74.9 | −72.6 | 2.39 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 232 / 5814 (4.0%) | 6314 / 58140 (10.9%) | −74.6 | −72.3 | 0.37 |
| CDK9 SRX20230567 | Ishikawa Uterus | 694 / 5814 (11.9%) | 3090 / 58140 (5.3%) | −74.4 | −72.1 | 2.25 |
| Epitope tags SRX7276677 | 293 Kidney | 1019 / 5814 (17.5%) | 5424 / 58140 (9.3%) | −74.2 | −71.9 | 1.88 |
| YAP1 SRX5718140 | 293 Kidney | 172 / 5814 (3.0%) | 5356 / 58140 (9.2%) | −74.0 | −71.6 | 0.32 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 96 / 5814 (1.7%) | 4044 / 58140 (7.0%) | −73.6 | −71.3 | 0.24 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 428 / 5814 (7.4%) | 1431 / 58140 (2.5%) | −73.5 | −71.2 | 2.99 |
| NR3C1 SRX2609662 | HASM2 Lung | 112 / 5814 (1.9%) | 4327 / 58140 (7.4%) | −73.4 | −71.1 | 0.26 |
| NR3C1 SRX2609665 | HASM2 Lung | 102 / 5814 (1.8%) | 4136 / 58140 (7.1%) | −73.1 | −70.8 | 0.25 |
| ASCL1 SRX8949802 | Unclassified Unclassified | 677 / 5814 (11.6%) | 3004 / 58140 (5.2%) | −73.0 | −70.7 | 2.25 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 68 / 5814 (1.2%) | 3493 / 58140 (6.0%) | −73.0 | −70.7 | 0.19 |
| JUNB SRX8488073 | SUM 229PE Breast | 201 / 5814 (3.5%) | 5775 / 58140 (9.9%) | −72.8 | −70.5 | 0.35 |
| DDX21 SRX8257415 | A-375 Epidermis | 378 / 5814 (6.5%) | 1167 / 58140 (2.0%) | −72.5 | −70.2 | 3.24 |
| PBX3 SRX190343 | SK-N-SH Neural | 218 / 5814 (3.7%) | 6022 / 58140 (10.4%) | −72.3 | −70.0 | 0.36 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 493 / 5814 (8.5%) | 1835 / 58140 (3.2%) | −72.3 | −70.0 | 2.69 |
| CTCF SRX12008354 | MCF 10A Breast | 1450 / 5814 (24.9%) | 8890 / 58140 (15.3%) | −72.1 | −69.8 | 1.63 |
| PRRX1 SRX15235713 | Hs 578T Breast | 120 / 5814 (2.1%) | 4423 / 58140 (7.6%) | −72.0 | −69.7 | 0.27 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 202 / 5814 (3.5%) | 5758 / 58140 (9.9%) | −71.8 | −69.5 | 0.35 |
| NR3C1 SRX2609661 | HASM2 Lung | 109 / 5814 (1.9%) | 4216 / 58140 (7.3%) | −71.6 | −69.3 | 0.26 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 105 / 5814 (1.8%) | 48 / 58140 (0.1%) | −71.5 | −69.2 | 21.88 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 596 / 5814 (10.3%) | 2498 / 58140 (4.3%) | −71.4 | −69.1 | 2.39 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 60 / 5814 (1.0%) | 3278 / 58140 (5.6%) | −71.1 | −68.8 | 0.18 |
| MBD3 SRX1674506 | HeLa Uterus | 965 / 5814 (16.6%) | 5107 / 58140 (8.8%) | −70.9 | −68.7 | 1.89 |
| CEBPB SRX150598 | IMR-90 Lung | 214 / 5814 (3.7%) | 5914 / 58140 (10.2%) | −70.9 | −68.6 | 0.36 |
| SMARCA4 SRX5212362 | Mel270 Others | 181 / 5814 (3.1%) | 5392 / 58140 (9.3%) | −70.8 | −68.5 | 0.34 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 523 / 5814 (9.0%) | 2044 / 58140 (3.5%) | −70.6 | −68.4 | 2.56 |
| MCM3 SRX9107920 | hTERT RPE-1 Neural | 373 / 5814 (6.4%) | 1168 / 58140 (2.0%) | −70.2 | −67.9 | 3.19 |
| ING5 SRX286202 | RKO Digestive tract | 496 / 5814 (8.5%) | 1889 / 58140 (3.2%) | −70.0 | −67.8 | 2.63 |
| FOXL2 SRX6957477 | KGN Gonad | 92 / 5814 (1.6%) | 3854 / 58140 (6.6%) | −69.8 | −67.5 | 0.24 |
| SMARCA4 SRX5212366 | Mel270 Others | 139 / 5814 (2.4%) | 4668 / 58140 (8.0%) | −69.4 | −67.2 | 0.30 |
| FOS SRX150477 | MCF 10A Breast | 265 / 5814 (4.6%) | 6613 / 58140 (11.4%) | −69.0 | −66.8 | 0.40 |
| RELA SRX7055007 | HAEC Cardiovascular | 194 / 5814 (3.3%) | 5532 / 58140 (9.5%) | −68.8 | −66.6 | 0.35 |
| RBM22 SRX4708083 | K-562 Blood | 376 / 5814 (6.5%) | 1203 / 58140 (2.1%) | −68.7 | −66.5 | 3.13 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 246 / 5814 (4.2%) | 6321 / 58140 (10.9%) | −68.7 | −66.5 | 0.39 |
| FOS SRX4192880 | MCF 10A Breast | 188 / 5814 (3.2%) | 5426 / 58140 (9.3%) | −68.5 | −66.3 | 0.35 |
| FOS SRX150478 | MCF 10A Breast | 280 / 5814 (4.8%) | 6811 / 58140 (11.7%) | −68.5 | −66.3 | 0.41 |
| ASCL1 SRX8949803 | Unclassified Unclassified | 716 / 5814 (12.3%) | 3365 / 58140 (5.8%) | −68.4 | −66.2 | 2.13 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 62 / 5814 (1.1%) | 3237 / 58140 (5.6%) | −68.3 | −66.1 | 0.19 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 437 / 5814 (7.5%) | 1559 / 58140 (2.7%) | −68.2 | −65.9 | 2.80 |
| MED1 SRX8707939 | Keratinocytes Epidermis | 318 / 5814 (5.5%) | 899 / 58140 (1.5%) | −68.0 | −65.8 | 3.54 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 148 / 5814 (2.5%) | 4768 / 58140 (8.2%) | −68.0 | −65.7 | 0.31 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 702 / 5814 (12.1%) | 3282 / 58140 (5.6%) | −67.9 | −65.7 | 2.14 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 214 / 5814 (3.7%) | 5803 / 58140 (10.0%) | −67.8 | −65.5 | 0.37 |
| KAT6A SRX20971022 | Fibroblasts Others | 96 / 5814 (1.7%) | 39 / 58140 (0.1%) | −67.7 | −65.5 | 24.62 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 78 / 5814 (1.3%) | 3532 / 58140 (6.1%) | −67.6 | −65.4 | 0.22 |
| FOXA1 SRX176862 | MCF-7 Breast | 138 / 5814 (2.4%) | 4591 / 58140 (7.9%) | −67.6 | −65.4 | 0.30 |
| LEO1 SRX1873456 | SEM Blood | 536 / 5814 (9.2%) | 2192 / 58140 (3.8%) | −66.9 | −64.7 | 2.45 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 597 / 5814 (10.3%) | 2591 / 58140 (4.5%) | −66.8 | −64.6 | 2.30 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 631 / 5814 (10.9%) | 2817 / 58140 (4.8%) | −66.8 | −64.6 | 2.24 |
| FOXA1 SRX176863 | MCF-7 Breast | 126 / 5814 (2.2%) | 4355 / 58140 (7.5%) | −66.6 | −64.4 | 0.29 |
| SSRP1 SRX3436566 | HT-1080 Bone | 133 / 5814 (2.3%) | 130 / 58140 (0.2%) | −66.5 | −64.3 | 10.23 |
| Epitope tags SRX4892334 | 293 Kidney | 874 / 5814 (15.0%) | 4550 / 58140 (7.8%) | −66.5 | −64.3 | 1.92 |
| RBFOX2 SRX3323051 | Hep G2 Liver | 563 / 5814 (9.7%) | 2377 / 58140 (4.1%) | −66.4 | −64.2 | 2.37 |
| JUN SRX7277180 | GM07492 Others | 79 / 5814 (1.4%) | 3510 / 58140 (6.0%) | −66.3 | −64.1 | 0.23 |
| SMARCA4 SRX5212357 | Mel270 Others | 154 / 5814 (2.6%) | 4804 / 58140 (8.3%) | −66.2 | −64.0 | 0.32 |
| Epitope tags SRX3657345 | 293 Kidney | 871 / 5814 (15.0%) | 4538 / 58140 (7.8%) | −66.1 | −63.9 | 1.92 |
| FOS SRX070879 | HUVEC Cardiovascular | 110 / 5814 (1.9%) | 4063 / 58140 (7.0%) | −66.0 | −63.8 | 0.27 |
| JUND SRX190357 | SK-N-SH Neural | 132 / 5814 (2.3%) | 4437 / 58140 (7.6%) | −66.0 | −63.8 | 0.30 |
| FOXA2 SRX3644342 | BJ Epidermis | 156 / 5814 (2.7%) | 4826 / 58140 (8.3%) | −65.8 | −63.7 | 0.32 |
| JUN SRX150358 | HUVEC Cardiovascular | 57 / 5814 (1.0%) | 3065 / 58140 (5.3%) | −65.7 | −63.5 | 0.19 |
| TET2 SRX1427029 | 293 Kidney | 494 / 5814 (8.5%) | 1951 / 58140 (3.4%) | −65.5 | −63.3 | 2.53 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 129 / 5814 (2.2%) | 123 / 58140 (0.2%) | −65.3 | −63.1 | 10.49 |
| FOXL2 SRX5342375 | SVOG-3e Gonad | 72 / 5814 (1.2%) | 3337 / 58140 (5.7%) | −64.9 | −62.7 | 0.22 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 271 / 5814 (4.7%) | 697 / 58140 (1.2%) | −64.6 | −62.5 | 3.89 |
| JUN SRX2355072 | HAEC Cardiovascular | 143 / 5814 (2.5%) | 4574 / 58140 (7.9%) | −64.6 | −62.4 | 0.31 |
| FLI1 SRX9738674 | A-673 Bone | 105 / 5814 (1.8%) | 3925 / 58140 (6.8%) | −64.5 | −62.3 | 0.27 |
| EP300 SRX100540 | SK-N-SH Neural | 157 / 5814 (2.7%) | 4798 / 58140 (8.3%) | −64.4 | −62.3 | 0.33 |
| RELA SRX7054617 | HAEC Cardiovascular | 131 / 5814 (2.3%) | 4365 / 58140 (7.5%) | −64.3 | −62.1 | 0.30 |
| SMARCA4 SRX5716469 | Neural progenitor cells Neural | 63 / 5814 (1.1%) | 3143 / 58140 (5.4%) | −64.2 | −62.0 | 0.20 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 144 / 5814 (2.5%) | 4578 / 58140 (7.9%) | −64.2 | −62.0 | 0.31 |
| MAU2 SRX15710550 | Fibroblasts Others | 186 / 5814 (3.2%) | 5239 / 58140 (9.0%) | −64.0 | −61.8 | 0.36 |
| CBFB SRX265218 | ME-1 Blood | 556 / 5814 (9.6%) | 2376 / 58140 (4.1%) | −63.9 | −61.8 | 2.34 |
| FOSL2 SRX190296 | SK-N-SH Neural | 148 / 5814 (2.5%) | 4626 / 58140 (8.0%) | −63.7 | −61.5 | 0.32 |
| ATF3 SRX2207918 | CS1AN Epidermis | 837 / 5814 (14.4%) | 4348 / 58140 (7.5%) | −63.6 | −61.5 | 1.93 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 208 / 5814 (3.6%) | 5567 / 58140 (9.6%) | −63.6 | −61.5 | 0.37 |
| KLF3 SRX7214021 | Keratinocytes Epidermis | 638 / 5814 (11.0%) | 2934 / 58140 (5.0%) | −63.5 | −61.4 | 2.17 |
| NFYB SRX16608147 | HeLa Uterus | 117 / 5814 (2.0%) | 97 / 58140 (0.2%) | −63.5 | −61.3 | 12.06 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 200 / 5814 (3.4%) | 5435 / 58140 (9.3%) | −63.4 | −61.2 | 0.37 |
| KLF3 SRX7214022 | Keratinocytes Epidermis | 657 / 5814 (11.3%) | 3070 / 58140 (5.3%) | −63.4 | −61.2 | 2.14 |
| SUZ12 SRX10184494 | K-562 Blood | 911 / 5814 (15.7%) | 4927 / 58140 (8.5%) | −62.8 | −60.6 | 1.85 |
| MEAF6 DRX234811 | 293 Kidney | 605 / 5814 (10.4%) | 2725 / 58140 (4.7%) | −62.8 | −60.6 | 2.22 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 592 / 5814 (10.2%) | 2640 / 58140 (4.5%) | −62.7 | −60.6 | 2.24 |
| SMARCA4 SRX5212371 | Mel270 Others | 158 / 5814 (2.7%) | 4735 / 58140 (8.1%) | −62.2 | −60.0 | 0.33 |
| ASCL1 SRX8949797 | Unclassified Unclassified | 750 / 5814 (12.9%) | 3762 / 58140 (6.5%) | −61.8 | −59.7 | 1.99 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 346 / 5814 (6.0%) | 7480 / 58140 (12.9%) | −61.7 | −59.5 | 0.46 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 202 / 5814 (3.5%) | 5400 / 58140 (9.3%) | −61.5 | −59.4 | 0.37 |
| FOXA1 SRX3931044 | MCF-7 Breast | 251 / 5814 (4.3%) | 6122 / 58140 (10.5%) | −61.3 | −59.2 | 0.41 |
| CDK9 SRX20230570 | Ishikawa Uterus | 634 / 5814 (10.9%) | 2961 / 58140 (5.1%) | −61.0 | −58.9 | 2.14 |
| JUN SRX6582163 | BJ-5ta Epidermis | 140 / 5814 (2.4%) | 4406 / 58140 (7.6%) | −61.0 | −58.8 | 0.32 |
| ESR1 SRX2901942 | Ishikawa Uterus | 444 / 5814 (7.6%) | 1721 / 58140 (3.0%) | −60.6 | −58.5 | 2.58 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 228 / 5814 (3.9%) | 5750 / 58140 (9.9%) | −60.4 | −58.3 | 0.40 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 627 / 5814 (10.8%) | 2929 / 58140 (5.0%) | −60.3 | −58.2 | 2.14 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 326 / 5814 (5.6%) | 1033 / 58140 (1.8%) | −60.2 | −58.1 | 3.16 |
| CDK9 SRX20230573 | Ishikawa Uterus | 796 / 5814 (13.7%) | 4139 / 58140 (7.1%) | −60.2 | −58.0 | 1.92 |
| KAT7 DRX234808 | 293 Kidney | 296 / 5814 (5.1%) | 873 / 58140 (1.5%) | −60.1 | −57.9 | 3.39 |
| FOXA1 SRX1161177 | MCF-7 Breast | 117 / 5814 (2.0%) | 3993 / 58140 (6.9%) | −60.1 | −57.9 | 0.29 |
| CTCF SRX10976001 | NALM-6 Blood | 910 / 5814 (15.7%) | 4998 / 58140 (8.6%) | −60.0 | −57.9 | 1.82 |
| ZFX SRX7805370 | 293 Kidney | 431 / 5814 (7.4%) | 1650 / 58140 (2.8%) | −59.9 | −57.8 | 2.61 |
| SP1 SRX113706 | HCT 116 Digestive tract | 677 / 5814 (11.6%) | 3286 / 58140 (5.7%) | −59.9 | −57.8 | 2.06 |
| FOS SRX150664 | HUVEC Cardiovascular | 155 / 5814 (2.7%) | 4608 / 58140 (7.9%) | −59.8 | −57.7 | 0.34 |
| TET2 SRX2513053 | Jurkat Blood | 771 / 5814 (13.3%) | 3964 / 58140 (6.8%) | −59.8 | −57.7 | 1.95 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 155 / 5814 (2.7%) | 4606 / 58140 (7.9%) | −59.7 | −57.6 | 0.34 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 144 / 5814 (2.5%) | 4427 / 58140 (7.6%) | −59.6 | −57.5 | 0.33 |
| RELA SRX7054663 | HAEC Cardiovascular | 93 / 5814 (1.6%) | 3561 / 58140 (6.1%) | −59.6 | −57.5 | 0.26 |
| EP300 SRX11470503 | Mesenchymal stem cells Others | 119 / 5814 (2.0%) | 4012 / 58140 (6.9%) | −59.6 | −57.5 | 0.30 |
| CNOT3 SRX886388 | Colorectal carcinoma Digestive tract | 709 / 5814 (12.2%) | 3532 / 58140 (6.1%) | −59.3 | −57.2 | 2.01 |
| FOXL2 SRX6957481 | KGN Gonad | 60 / 5814 (1.0%) | 2939 / 58140 (5.1%) | −59.2 | −57.1 | 0.20 |
| KMT2A SRX8151120 | VDH-15 Others | 754 / 5814 (13.0%) | 3857 / 58140 (6.6%) | −59.2 | −57.1 | 1.95 |
| WAS SRX5371250 | GM11518 Blood | 419 / 5814 (7.2%) | 1592 / 58140 (2.7%) | −59.0 | −56.9 | 2.63 |
| KLF4 SRX12144702 | T/C28a2 Bone | 887 / 5814 (15.3%) | 4851 / 58140 (8.3%) | −58.9 | −56.9 | 1.83 |
| NKX2-1 SRX2164786 | A549 Lung | 197 / 5814 (3.4%) | 5231 / 58140 (9.0%) | −58.9 | −56.8 | 0.38 |
| ATF1 SRX11470442 | Mesenchymal stem cells Others | 148 / 5814 (2.5%) | 4468 / 58140 (7.7%) | −58.9 | −56.8 | 0.33 |
| GATA3 SRX176864 | MCF-7 Breast | 80 / 5814 (1.4%) | 3306 / 58140 (5.7%) | −58.9 | −56.8 | 0.24 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 222 / 5814 (3.8%) | 517 / 58140 (0.9%) | −58.8 | −56.7 | 4.29 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 119 / 5814 (2.0%) | 3982 / 58140 (6.8%) | −58.7 | −56.6 | 0.30 |
| KAT7 DRX300414 | 293 Kidney | 234 / 5814 (4.0%) | 576 / 58140 (1.0%) | −58.5 | −56.4 | 4.06 |
| TFEB SRX6743819 | iPS cells Pluripotent stem cell | 540 / 5814 (9.3%) | 2377 / 58140 (4.1%) | −58.4 | −56.3 | 2.27 |
| FOXA1 SRX1161175 | MCF-7 Breast | 85 / 5814 (1.5%) | 3382 / 58140 (5.8%) | −58.4 | −56.3 | 0.25 |
| FOXA1 SRX219284 | LNCAP Prostate | 157 / 5814 (2.7%) | 4589 / 58140 (7.9%) | −58.3 | −56.2 | 0.34 |
| FOXA1 SRX1161173 | MCF-7 Breast | 93 / 5814 (1.6%) | 3520 / 58140 (6.1%) | −58.3 | −56.2 | 0.26 |
| EP300 SRX2194266 | SUM 159PT Breast | 203 / 5814 (3.5%) | 5293 / 58140 (9.1%) | −58.1 | −56.0 | 0.38 |
| ETS1 SRX3033231 | HEYA8 Gonad | 124 / 5814 (2.1%) | 137 / 58140 (0.2%) | −58.0 | −56.0 | 9.05 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 155 / 5814 (2.7%) | 4550 / 58140 (7.8%) | −58.0 | −56.0 | 0.34 |
| CDK9 SRX20230574 | Ishikawa Uterus | 554 / 5814 (9.5%) | 2480 / 58140 (4.3%) | −58.0 | −56.0 | 2.23 |
| JUN SRX6582164 | BJ-5ta Epidermis | 147 / 5814 (2.5%) | 4418 / 58140 (7.6%) | −57.9 | −55.9 | 0.33 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 168 / 5814 (2.9%) | 4742 / 58140 (8.2%) | −57.8 | −55.7 | 0.35 |
| JUN SRX6582165 | BJ-5ta Epidermis | 230 / 5814 (4.0%) | 5680 / 58140 (9.8%) | −57.7 | −55.6 | 0.40 |
| MEAF6 DRX300417 | 293 Kidney | 546 / 5814 (9.4%) | 2439 / 58140 (4.2%) | −57.5 | −55.4 | 2.24 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 546 / 5814 (9.4%) | 2439 / 58140 (4.2%) | −57.5 | −55.4 | 2.24 |
| MYOCD SRX5598318 | A549 Lung | 626 / 5814 (10.8%) | 2989 / 58140 (5.1%) | −57.3 | −55.3 | 2.09 |
| EP300 SRX11470502 | Mesenchymal stem cells Others | 100 / 5814 (1.7%) | 3615 / 58140 (6.2%) | −57.3 | −55.3 | 0.28 |
| NR3C1 SRX2609667 | HASM2 Lung | 115 / 5814 (2.0%) | 3866 / 58140 (6.6%) | −57.2 | −55.2 | 0.30 |
| KMT2A SRX2281249 | SEM Blood | 686 / 5814 (11.8%) | 3417 / 58140 (5.9%) | −57.2 | −55.2 | 2.01 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 93 / 5814 (1.6%) | 3490 / 58140 (6.0%) | −57.2 | −55.2 | 0.27 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 185 / 5814 (3.2%) | 366 / 58140 (0.6%) | −57.2 | −55.1 | 5.05 |
| GATA3 SRX5057632 | MCF-7 Breast | 72 / 5814 (1.2%) | 3108 / 58140 (5.3%) | −57.2 | −55.1 | 0.23 |
| BRD4 SRX8082233 | Keratinocytes Epidermis | 603 / 5814 (10.4%) | 2835 / 58140 (4.9%) | −57.1 | −55.0 | 2.13 |
| CTCF SRX10976000 | NALM-6 Blood | 1022 / 5814 (17.6%) | 5954 / 58140 (10.2%) | −57.0 | −55.0 | 1.72 |
| MethylCap SRX026646 | Acute myeloid leukemia Blood | 250 / 5814 (4.3%) | 669 / 58140 (1.2%) | −57.0 | −55.0 | 3.74 |
| JUND SRX699738 | HCASMC Cardiovascular | 166 / 5814 (2.9%) | 4678 / 58140 (8.0%) | −56.8 | −54.8 | 0.35 |
| CTCF SRX10976007 | NALM-6 Blood | 909 / 5814 (15.6%) | 5086 / 58140 (8.7%) | −56.8 | −54.7 | 1.79 |
| BCOR SRX10184493 | K-562 Blood | 773 / 5814 (13.3%) | 4063 / 58140 (7.0%) | −56.7 | −54.7 | 1.90 |
| TEAD1 SRX716558 | SF268 Neural | 50 / 5814 (0.9%) | 2663 / 58140 (4.6%) | −56.6 | −54.6 | 0.19 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 145 / 5814 (2.5%) | 4339 / 58140 (7.5%) | −56.6 | −54.5 | 0.33 |
| Epitope tags SRX15426925 | Keratinocytes Epidermis | 210 / 5814 (3.6%) | 482 / 58140 (0.8%) | −56.5 | −54.4 | 4.36 |
| FOXO1 SRX1048948 | Endometrial stromal cells Uterus | 46 / 5814 (0.8%) | 2575 / 58140 (4.4%) | −56.3 | −54.3 | 0.18 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 213 / 5814 (3.7%) | 5375 / 58140 (9.2%) | −56.3 | −54.3 | 0.40 |
| SNAI2 SRX476921 | Keratinocytes Epidermis | 768 / 5814 (13.2%) | 4038 / 58140 (6.9%) | −56.3 | −54.2 | 1.90 |
| KMT2A SRX1293531 | MV-4-11 Blood | 886 / 5814 (15.2%) | 4930 / 58140 (8.5%) | −56.0 | −53.9 | 1.80 |
| JUNB SRX4192882 | MCF 10A Breast | 90 / 5814 (1.5%) | 3394 / 58140 (5.8%) | −55.9 | −53.9 | 0.27 |
| FOXA2 SRX3230382 | Hep G2 Liver | 172 / 5814 (3.0%) | 4734 / 58140 (8.1%) | −55.8 | −53.7 | 0.36 |
| JUNB SRX10119386 | MCF 10A Breast | 108 / 5814 (1.9%) | 3695 / 58140 (6.4%) | −55.6 | −53.6 | 0.29 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 156 / 5814 (2.7%) | 4476 / 58140 (7.7%) | −55.4 | −53.4 | 0.35 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 317 / 5814 (5.5%) | 1045 / 58140 (1.8%) | −55.4 | −53.4 | 3.03 |
| CEBPB SRX150632 | HeLa Uterus | 279 / 5814 (4.8%) | 6297 / 58140 (10.8%) | −55.4 | −53.3 | 0.44 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 193 / 5814 (3.3%) | 5042 / 58140 (8.7%) | −55.3 | −53.3 | 0.38 |
| RELA SRX7054657 | HAEC Cardiovascular | 137 / 5814 (2.4%) | 4154 / 58140 (7.1%) | −55.0 | −53.0 | 0.33 |
| TFAP2A SRX20744801 | GP5d Digestive tract | 358 / 5814 (6.2%) | 1288 / 58140 (2.2%) | −55.0 | −52.9 | 2.78 |
| CEBPB SRX2194250 | SUM 159PT Breast | 145 / 5814 (2.5%) | 4280 / 58140 (7.4%) | −54.9 | −52.9 | 0.34 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 167 / 5814 (2.9%) | 4629 / 58140 (8.0%) | −54.9 | −52.9 | 0.36 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 453 / 5814 (7.8%) | 1880 / 58140 (3.2%) | −54.6 | −52.6 | 2.41 |
| Epitope tags SRX2255895 | 293 Kidney | 353 / 5814 (6.1%) | 1265 / 58140 (2.2%) | −54.6 | −52.6 | 2.79 |
| CEBPB SRX7807101 | Unclassified Unclassified | 83 / 5814 (1.4%) | 3224 / 58140 (5.5%) | −54.5 | −52.5 | 0.26 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 162 / 5814 (2.8%) | 4535 / 58140 (7.8%) | −54.5 | −52.5 | 0.36 |
| YAP1 SRX1038944 | IMR-90 Lung | 38 / 5814 (0.7%) | 2355 / 58140 (4.1%) | −54.5 | −52.5 | 0.16 |
| RELA SRX7054666 | HAEC Cardiovascular | 186 / 5814 (3.2%) | 4902 / 58140 (8.4%) | −54.4 | −52.4 | 0.38 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 167 / 5814 (2.9%) | 4607 / 58140 (7.9%) | −54.4 | −52.4 | 0.36 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 165 / 5814 (2.8%) | 4579 / 58140 (7.9%) | −54.4 | −52.4 | 0.36 |
| ERG SRX063918 | MCF-7 Breast | 537 / 5814 (9.2%) | 2441 / 58140 (4.2%) | −54.3 | −52.3 | 2.20 |
| FOXA1 SRX371480 | MCF-7 Breast | 81 / 5814 (1.4%) | 3181 / 58140 (5.5%) | −54.2 | −52.2 | 0.25 |
| SMARCA4 SRX5716470 | Neural progenitor cells Neural | 101 / 5814 (1.7%) | 3525 / 58140 (6.1%) | −54.0 | −52.0 | 0.29 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 195 / 5814 (3.4%) | 5019 / 58140 (8.6%) | −53.9 | −51.9 | 0.39 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 100 / 5814 (1.7%) | 3505 / 58140 (6.0%) | −53.8 | −51.8 | 0.29 |
| FOXA1 SRX11222437 | MCF-7 Breast | 85 / 5814 (1.5%) | 3241 / 58140 (5.6%) | −53.8 | −51.8 | 0.26 |
| TET1 SRX10382426 | hESC H1 Pluripotent stem cell | 854 / 5814 (14.7%) | 4755 / 58140 (8.2%) | −53.7 | −51.7 | 1.80 |
| FLI1 SRX10198034 | A-673 Bone | 71 / 5814 (1.2%) | 2982 / 58140 (5.1%) | −53.6 | −51.6 | 0.24 |
| FOSL2 SRX190204 | A549 Lung | 118 / 5814 (2.0%) | 3800 / 58140 (6.5%) | −53.6 | −51.6 | 0.31 |
| Epitope tags SRX15939724 | RD Muscle | 100 / 5814 (1.7%) | 3496 / 58140 (6.0%) | −53.6 | −51.6 | 0.29 |
| KMT2A SRX8151117 | VDH-15 Others | 739 / 5814 (12.7%) | 3899 / 58140 (6.7%) | −53.5 | −51.5 | 1.90 |
| FOXA1 SRX371482 | MCF-7 Breast | 185 / 5814 (3.2%) | 4847 / 58140 (8.3%) | −53.4 | −51.4 | 0.38 |
| G3BP1 SRX24196609 | KGN Gonad | 576 / 5814 (9.9%) | 2739 / 58140 (4.7%) | −53.1 | −51.1 | 2.10 |
| HDAC1 SRX20517422 | Keratinocytes Epidermis | 487 / 5814 (8.4%) | 2133 / 58140 (3.7%) | −53.1 | −51.1 | 2.28 |
| FOXA1 SRX11222441 | MCF-7 Breast | 92 / 5814 (1.6%) | 3337 / 58140 (5.7%) | −53.0 | −51.0 | 0.28 |
| KMT2A SRX8151118 | VDH-15 Others | 704 / 5814 (12.1%) | 3658 / 58140 (6.3%) | −52.8 | −50.8 | 1.92 |
| CDK9 SRX20230572 | Ishikawa Uterus | 613 / 5814 (10.5%) | 3005 / 58140 (5.2%) | −52.8 | −50.8 | 2.04 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 118 / 5814 (2.0%) | 3770 / 58140 (6.5%) | −52.8 | −50.8 | 0.31 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 118 / 5814 (2.0%) | 3773 / 58140 (6.5%) | −52.8 | −50.8 | 0.31 |
| BMI1 SRX8726297 | Tumor Others | 559 / 5814 (9.6%) | 2628 / 58140 (4.5%) | −52.7 | −50.7 | 2.13 |
| EP300 SRX190219 | SK-N-SH Neural | 120 / 5814 (2.1%) | 3797 / 58140 (6.5%) | −52.6 | −50.6 | 0.32 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 184 / 5814 (3.2%) | 4801 / 58140 (8.3%) | −52.4 | −50.5 | 0.38 |
| ARID1A SRX5679787 | 12Z Others | 40 / 5814 (0.7%) | 2341 / 58140 (4.0%) | −52.4 | −50.4 | 0.17 |
| BCORL1 SRX10184497 | K-562 Blood | 709 / 5814 (12.2%) | 3708 / 58140 (6.4%) | −52.4 | −50.4 | 1.91 |
| Epitope tags SRX4192709 | MDA-MB-231 Breast | 209 / 5814 (3.6%) | 514 / 58140 (0.9%) | −52.3 | −50.4 | 4.07 |
| CHD7 SRX3581511 | iPSC derived neural cells Pluripotent stem cell | 30 / 5814 (0.5%) | 2122 / 58140 (3.6%) | −52.3 | −50.3 | 0.14 |
| FOXA1 SRX1885181 | LNCAP Prostate | 109 / 5814 (1.9%) | 3606 / 58140 (6.2%) | −52.3 | −50.3 | 0.30 |
| CEBPA SRX4705113 | MOLM-13 Blood | 293 / 5814 (5.0%) | 6366 / 58140 (10.9%) | −52.2 | −50.3 | 0.46 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 286 / 5814 (4.9%) | 914 / 58140 (1.6%) | −52.2 | −50.2 | 3.13 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 228 / 5814 (3.9%) | 5439 / 58140 (9.4%) | −52.2 | −50.2 | 0.42 |
| FOXA1 SRX11222438 | MCF-7 Breast | 61 / 5814 (1.0%) | 2751 / 58140 (4.7%) | −52.2 | −50.2 | 0.22 |
| SNAI2 SRX476922 | Keratinocytes Epidermis | 779 / 5814 (13.4%) | 4233 / 58140 (7.3%) | −52.2 | −50.2 | 1.84 |
| RELA SRX7054661 | HAEC Cardiovascular | 211 / 5814 (3.6%) | 5191 / 58140 (8.9%) | −52.2 | −50.2 | 0.41 |
| RELA SRX7054618 | HAEC Cardiovascular | 124 / 5814 (2.1%) | 3844 / 58140 (6.6%) | −52.0 | −50.0 | 0.32 |
| KMT2A SRX8151119 | VDH-15 Others | 675 / 5814 (11.6%) | 3469 / 58140 (6.0%) | −52.0 | −50.0 | 1.95 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 140 / 5814 (2.4%) | 4101 / 58140 (7.1%) | −52.0 | −50.0 | 0.34 |
| BRD4 SRX8082232 | Keratinocytes Epidermis | 363 / 5814 (6.2%) | 1366 / 58140 (2.3%) | −51.9 | −49.9 | 2.66 |
| ASCL1 SRX11245139 | DMS 53 Lung | 521 / 5814 (9.0%) | 2390 / 58140 (4.1%) | −51.7 | −49.8 | 2.18 |
| TLE3 SRX4815191 | MCF-7 Breast | 133 / 5814 (2.3%) | 3977 / 58140 (6.8%) | −51.6 | −49.6 | 0.33 |
| FOXA1 SRX11222442 | MCF-7 Breast | 81 / 5814 (1.4%) | 3097 / 58140 (5.3%) | −51.5 | −49.6 | 0.26 |
| JUN SRX883584 | MDA-MB-231 Breast | 205 / 5814 (3.5%) | 5076 / 58140 (8.7%) | −51.5 | −49.6 | 0.40 |
| CEBPB SRX1027439 | Mesenchymal stem cells Others | 95 / 5814 (1.6%) | 3334 / 58140 (5.7%) | −51.3 | −49.4 | 0.28 |
| CEBPB SRX7807103 | Adipocytes Adipocyte | 111 / 5814 (1.9%) | 3606 / 58140 (6.2%) | −51.2 | −49.3 | 0.31 |
| JUN SRX2355073 | HAEC Cardiovascular | 165 / 5814 (2.8%) | 4464 / 58140 (7.7%) | −51.2 | −49.2 | 0.37 |
| RBFOX2 SRX3322781 | K-562 Blood | 688 / 5814 (11.8%) | 3586 / 58140 (6.2%) | −51.2 | −49.2 | 1.92 |
| FOXA1 SRX6878606 | LNCAP Prostate | 59 / 5814 (1.0%) | 2679 / 58140 (4.6%) | −51.2 | −49.2 | 0.22 |
| PHF6 SRX11508321 | G-401 Kidney | 536 / 5814 (9.2%) | 2506 / 58140 (4.3%) | −51.1 | −49.1 | 2.14 |
| FOXA1 SRX3923514 | MCF-7 Breast | 130 / 5814 (2.2%) | 3907 / 58140 (6.7%) | −51.1 | −49.1 | 0.33 |
| DMC1 SRX663450 | Testis Gonad | 212 / 5814 (3.6%) | 542 / 58140 (0.9%) | −50.9 | −49.0 | 3.91 |
| PAF1 SRX15147186 | DLD-1 Digestive tract | 283 / 5814 (4.9%) | 916 / 58140 (1.6%) | −50.8 | −48.8 | 3.09 |
| FOS SRX150476 | MCF 10A Breast | 230 / 5814 (4.0%) | 5415 / 58140 (9.3%) | −50.7 | −48.8 | 0.42 |
| ISL1 SRX16495323 | SK-N-SH Neural | 21 / 5814 (0.4%) | 1865 / 58140 (3.2%) | −50.7 | −48.8 | 0.11 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 265 / 5814 (4.6%) | 818 / 58140 (1.4%) | −50.7 | −48.7 | 3.24 |
| CEBPA SRX2630241 | Hep G2 Liver | 160 / 5814 (2.8%) | 4367 / 58140 (7.5%) | −50.6 | −48.7 | 0.37 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 225 / 5814 (3.9%) | 5336 / 58140 (9.2%) | −50.6 | −48.7 | 0.42 |
| FOXA1 SRX1161176 | MCF-7 Breast | 130 / 5814 (2.2%) | 3889 / 58140 (6.7%) | −50.5 | −48.6 | 0.33 |
| Epitope tags SRX4192708 | MDA-MB-231 Breast | 366 / 5814 (6.3%) | 1407 / 58140 (2.4%) | −50.5 | −48.6 | 2.60 |
| FOXA2 SRX100448 | Hep G2 Liver | 149 / 5814 (2.6%) | 4188 / 58140 (7.2%) | −50.5 | −48.5 | 0.36 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 110 / 5814 (1.9%) | 3558 / 58140 (6.1%) | −50.4 | −48.5 | 0.31 |
| FOXA1 SRX1787655 | MCF-7 Breast | 61 / 5814 (1.0%) | 2689 / 58140 (4.6%) | −50.2 | −48.3 | 0.23 |
| BCORL1 SRX10184498 | K-562 Blood | 721 / 5814 (12.4%) | 3858 / 58140 (6.6%) | −50.1 | −48.2 | 1.87 |
| RUNX1 SRX10119134 | MV-4-11 Blood | 111 / 5814 (1.9%) | 3556 / 58140 (6.1%) | −49.9 | −47.9 | 0.31 |
| SMARCA4 SRX8588625 | Pulmonary artery endothelial cells Cardiovascular | 139 / 5814 (2.4%) | 4007 / 58140 (6.9%) | −49.8 | −47.9 | 0.35 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 217 / 5814 (3.7%) | 5186 / 58140 (8.9%) | −49.8 | −47.8 | 0.42 |
| RELA SRX7054609 | HAEC Cardiovascular | 105 / 5814 (1.8%) | 3453 / 58140 (5.9%) | −49.7 | −47.8 | 0.30 |
| FOXA1 SRX028634 | MCF-7 Breast | 60 / 5814 (1.0%) | 2654 / 58140 (4.6%) | −49.7 | −47.8 | 0.23 |
| EP300 SRX22550927 | CDS1 Bone | 194 / 5814 (3.3%) | 4846 / 58140 (8.3%) | −49.6 | −47.7 | 0.40 |
| FOXA1 SRX2017929 | LNCAP Prostate | 175 / 5814 (3.0%) | 4558 / 58140 (7.8%) | −49.6 | −47.7 | 0.38 |
| FOXA1 SRX100506 | Hep G2 Liver | 181 / 5814 (3.1%) | 4646 / 58140 (8.0%) | −49.5 | −47.6 | 0.39 |
| FOXA1 SRX219285 | LNCAP Prostate | 120 / 5814 (2.1%) | 3696 / 58140 (6.4%) | −49.5 | −47.6 | 0.32 |
| RELA SRX2207671 | HUVEC Cardiovascular | 62 / 5814 (1.1%) | 2688 / 58140 (4.6%) | −49.5 | −47.6 | 0.23 |
| FOXA1 SRX6878603 | LNCAP Prostate | 150 / 5814 (2.6%) | 4174 / 58140 (7.2%) | −49.5 | −47.6 | 0.36 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 124 / 5814 (2.1%) | 3759 / 58140 (6.5%) | −49.5 | −47.6 | 0.33 |
| ISL1 SRX16495324 | SK-N-SH Neural | 24 / 5814 (0.4%) | 1905 / 58140 (3.3%) | −49.5 | −47.6 | 0.13 |
| ESR1 SRX371476 | MCF-7 Breast | 103 / 5814 (1.8%) | 3414 / 58140 (5.9%) | −49.5 | −47.6 | 0.30 |
| CEBPD SRX10059518 | Fibroblasts Others | 120 / 5814 (2.1%) | 3692 / 58140 (6.4%) | −49.4 | −47.5 | 0.33 |
| ARID1A SRX5679788 | 12Z Others | 49 / 5814 (0.8%) | 2433 / 58140 (4.2%) | −49.4 | −47.5 | 0.20 |
| SMARCA4 SRX9562891 | RH-4 Muscle | 64 / 5814 (1.1%) | 2722 / 58140 (4.7%) | −49.4 | −47.5 | 0.24 |
| DNA-RNA hybrid SRX15232261 | MDA-MB-436 Breast | 114 / 5814 (2.0%) | 144 / 58140 (0.2%) | −49.4 | −47.4 | 7.92 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 121 / 5814 (2.1%) | 3700 / 58140 (6.4%) | −49.3 | −47.4 | 0.33 |
| Epitope tags DRX443510 | 293 Kidney | 496 / 5814 (8.5%) | 2271 / 58140 (3.9%) | −49.3 | −47.4 | 2.18 |
| AFF4 SRX7615734 | MCF-7 Breast | 162 / 5814 (2.8%) | 327 / 58140 (0.6%) | −49.3 | −47.4 | 4.95 |
| OLIG2 SRX22544825 | Glioma Neural | 127 / 5814 (2.2%) | 3795 / 58140 (6.5%) | −49.2 | −47.3 | 0.33 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 252 / 5814 (4.3%) | 766 / 58140 (1.3%) | −49.2 | −47.3 | 3.29 |
| FOS SRX150517 | MCF 10A Breast | 228 / 5814 (3.9%) | 5322 / 58140 (9.2%) | −49.1 | −47.2 | 0.43 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 132 / 5814 (2.3%) | 3871 / 58140 (6.7%) | −49.0 | −47.1 | 0.34 |
| CEBPB SRX4394545 | SU-DHL-1 Bone | 123 / 5814 (2.1%) | 3725 / 58140 (6.4%) | −49.0 | −47.1 | 0.33 |
| MLLT3 SRX10131666 | Bronchial tracheal epithelial cells Lung | 87 / 5814 (1.5%) | 67 / 58140 (0.1%) | −49.0 | −47.1 | 12.99 |
| TEAD4 SRX10640863 | SK-MEL-147 Epidermis | 183 / 5814 (3.1%) | 4653 / 58140 (8.0%) | −48.9 | −47.0 | 0.39 |
| SMARCA4 SRX5982340 | A549 Lung | 49 / 5814 (0.8%) | 2420 / 58140 (4.2%) | −48.9 | −47.0 | 0.20 |
| CEBPB SRX2194247 | SUM 159PT Breast | 109 / 5814 (1.9%) | 3493 / 58140 (6.0%) | −48.9 | −47.0 | 0.31 |
| Epitope tags SRX15939725 | RD Muscle | 97 / 5814 (1.7%) | 3288 / 58140 (5.7%) | −48.8 | −46.9 | 0.30 |
| JUN SRX699737 | HCASMC Cardiovascular | 83 / 5814 (1.4%) | 3045 / 58140 (5.2%) | −48.8 | −46.9 | 0.27 |
| EP300 SRX150579 | HeLa Uterus | 83 / 5814 (1.4%) | 3046 / 58140 (5.2%) | −48.8 | −46.9 | 0.27 |
| CEBPB SRX2194249 | SUM 159PT Breast | 130 / 5814 (2.2%) | 3831 / 58140 (6.6%) | −48.8 | −46.9 | 0.34 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 91 / 5814 (1.6%) | 3185 / 58140 (5.5%) | −48.7 | −46.8 | 0.29 |
| NR3C1 SRX2609668 | HASM2 Lung | 101 / 5814 (1.7%) | 3351 / 58140 (5.8%) | −48.7 | −46.8 | 0.30 |
| FOXA1 SRX1885185 | LNCAP Prostate | 97 / 5814 (1.7%) | 3285 / 58140 (5.7%) | −48.7 | −46.8 | 0.30 |
| FOXA1 SRX1885182 | LNCAP Prostate | 112 / 5814 (1.9%) | 3532 / 58140 (6.1%) | −48.6 | −46.7 | 0.32 |
| CEBPA SRX097095 | U-937 Blood | 101 / 5814 (1.7%) | 3348 / 58140 (5.8%) | −48.6 | −46.7 | 0.30 |
| TAF1 SRX11120885 | MCF-7 Breast | 585 / 5814 (10.1%) | 2909 / 58140 (5.0%) | −48.5 | −46.7 | 2.01 |
| CTCF SRX10976002 | NALM-6 Blood | 993 / 5814 (17.1%) | 6014 / 58140 (10.3%) | −48.5 | −46.6 | 1.65 |
| JUND SRX150408 | HeLa Uterus | 115 / 5814 (2.0%) | 3574 / 58140 (6.1%) | −48.4 | −46.5 | 0.32 |
| FOXA1 SRX1885184 | LNCAP Prostate | 122 / 5814 (2.1%) | 3685 / 58140 (6.3%) | −48.3 | −46.4 | 0.33 |
| MED1 SRX3946904 | Mesenchymal stem cells Others | 58 / 5814 (1.0%) | 2573 / 58140 (4.4%) | −48.2 | −46.3 | 0.23 |
| RELA SRX7054615 | HAEC Cardiovascular | 142 / 5814 (2.4%) | 3997 / 58140 (6.9%) | −48.2 | −46.3 | 0.36 |
| MED1 SRX8391104 | Head and neck squamous cell carcinoma Others | 188 / 5814 (3.2%) | 453 / 58140 (0.8%) | −48.1 | −46.3 | 4.15 |
| FOXA1 SRX5323845 | MCF-7 Breast | 44 / 5814 (0.8%) | 2297 / 58140 (4.0%) | −48.1 | −46.2 | 0.19 |
| FOXA1 SRX371483 | MCF-7 Breast | 157 / 5814 (2.7%) | 4228 / 58140 (7.3%) | −48.1 | −46.2 | 0.37 |
| FOXA1 SRX100454 | T-47D Breast | 180 / 5814 (3.1%) | 4581 / 58140 (7.9%) | −48.1 | −46.2 | 0.39 |
| FOXA1 SRX5323843 | MCF-7 Breast | 67 / 5814 (1.2%) | 2738 / 58140 (4.7%) | −48.1 | −46.2 | 0.24 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 129 / 5814 (2.2%) | 3790 / 58140 (6.5%) | −48.1 | −46.2 | 0.34 |
| FOXA1 SRX667987 | VCaP Prostate | 98 / 5814 (1.7%) | 3283 / 58140 (5.6%) | −48.1 | −46.2 | 0.30 |
| Epitope tags SRX1457740 | 293 Kidney | 322 / 5814 (5.5%) | 1178 / 58140 (2.0%) | −48.1 | −46.2 | 2.73 |
| KMT2A SRX8151121 | VDH-15 Others | 731 / 5814 (12.6%) | 3993 / 58140 (6.9%) | −47.9 | −46.1 | 1.83 |
| EP300 SRX2194265 | SUM 159PT Breast | 210 / 5814 (3.6%) | 5012 / 58140 (8.6%) | −47.9 | −46.0 | 0.42 |
| FOXA1 SRX190181 | A549 Lung | 92 / 5814 (1.6%) | 3170 / 58140 (5.5%) | −47.9 | −46.0 | 0.29 |
| FOXA1 SRX2017928 | LNCAP Prostate | 155 / 5814 (2.7%) | 4188 / 58140 (7.2%) | −47.8 | −46.0 | 0.37 |
| GATA2 SRX150427 | HUVEC Cardiovascular | 70 / 5814 (1.2%) | 2780 / 58140 (4.8%) | −47.8 | −45.9 | 0.25 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 293 / 5814 (5.0%) | 6181 / 58140 (10.6%) | −47.7 | −45.9 | 0.47 |
| FOXA1 SRX1885187 | LNCAP Prostate | 78 / 5814 (1.3%) | 2924 / 58140 (5.0%) | −47.7 | −45.9 | 0.27 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 88 / 5814 (1.5%) | 3097 / 58140 (5.3%) | −47.7 | −45.9 | 0.28 |
| EP300 SRX147007 | IMR-90 Lung | 114 / 5814 (2.0%) | 3536 / 58140 (6.1%) | −47.7 | −45.8 | 0.32 |
| FOXA1 SRX497613 | VCaP Prostate | 92 / 5814 (1.6%) | 3168 / 58140 (5.4%) | −47.7 | −45.8 | 0.29 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 424 / 5814 (7.3%) | 1827 / 58140 (3.1%) | −47.6 | −45.7 | 2.32 |
| RBFOX2 SRX3322782 | K-562 Blood | 643 / 5814 (11.1%) | 3354 / 58140 (5.8%) | −47.5 | −45.7 | 1.92 |
| TEAD1 SRX716559 | SF268 Neural | 21 / 5814 (0.4%) | 1783 / 58140 (3.1%) | −47.5 | −45.7 | 0.12 |
| RUNX1 SRX10119135 | MV-4-11 Blood | 141 / 5814 (2.4%) | 3961 / 58140 (6.8%) | −47.5 | −45.6 | 0.36 |
| EP300 SRX212184 | Lung fibroblasts Lung | 115 / 5814 (2.0%) | 3540 / 58140 (6.1%) | −47.4 | −45.6 | 0.32 |
| RELA SRX7054621 | HAEC Cardiovascular | 111 / 5814 (1.9%) | 3474 / 58140 (6.0%) | −47.4 | −45.5 | 0.32 |
| Epitope tags SRX9005596 | TM5 Others | 1379 / 5814 (23.7%) | 9258 / 58140 (15.9%) | −47.3 | −45.5 | 1.49 |
| RELA SRX7055006 | HAEC Cardiovascular | 122 / 5814 (2.1%) | 3653 / 58140 (6.3%) | −47.3 | −45.5 | 0.33 |
| GATA2 SRX7767648 | Endometrial stromal cells Uterus | 36 / 5814 (0.6%) | 2111 / 58140 (3.6%) | −47.3 | −45.4 | 0.17 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 115 / 5814 (2.0%) | 3536 / 58140 (6.1%) | −47.3 | −45.4 | 0.33 |
| ARID5B SRX3230377 | Hep G2 Liver | 338 / 5814 (5.8%) | 6770 / 58140 (11.6%) | −47.3 | −45.4 | 0.50 |
| BCORL1 SRX10184496 | K-562 Blood | 680 / 5814 (11.7%) | 3631 / 58140 (6.2%) | −47.3 | −45.4 | 1.87 |
| INTS3 SRX3640569 | HeLa Uterus | 436 / 5814 (7.5%) | 1912 / 58140 (3.3%) | −47.3 | −45.4 | 2.28 |
| NABP2 SRX9523535 | HT-1080 Bone | 475 / 5814 (8.2%) | 2172 / 58140 (3.7%) | −47.2 | −45.4 | 2.19 |
| RELA SRX7054616 | HAEC Cardiovascular | 110 / 5814 (1.9%) | 3454 / 58140 (5.9%) | −47.2 | −45.4 | 0.32 |
| FOXA1 SRX5203303 | MCF-7 Breast | 44 / 5814 (0.8%) | 2270 / 58140 (3.9%) | −47.2 | −45.3 | 0.19 |
| FOXA1 SRX5323846 | MCF-7 Breast | 47 / 5814 (0.8%) | 2331 / 58140 (4.0%) | −47.1 | −45.3 | 0.20 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 146 / 5814 (2.5%) | 4023 / 58140 (6.9%) | −47.1 | −45.3 | 0.36 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 110 / 5814 (1.9%) | 3447 / 58140 (5.9%) | −47.1 | −45.3 | 0.32 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 45 / 5814 (0.8%) | 2287 / 58140 (3.9%) | −47.1 | −45.2 | 0.20 |
| BRD4 SRX5213646 | HCC1937 Breast | 358 / 5814 (6.2%) | 1413 / 58140 (2.4%) | −47.1 | −45.2 | 2.53 |
| FOXA1 SRX667984 | VCaP Prostate | 85 / 5814 (1.5%) | 3024 / 58140 (5.2%) | −47.0 | −45.1 | 0.28 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 106 / 5814 (1.8%) | 3375 / 58140 (5.8%) | −46.9 | −45.1 | 0.31 |
| YAP1 SRX10119364 | MCF 10A Breast | 115 / 5814 (2.0%) | 3521 / 58140 (6.1%) | −46.9 | −45.0 | 0.33 |
| NUP98 SRX20419392 | Keratinocytes Epidermis | 84 / 5814 (1.4%) | 66 / 58140 (0.1%) | −46.9 | −45.0 | 12.73 |
| NOTCH1 SRX2207669 | HUVEC Cardiovascular | 43 / 5814 (0.7%) | 2243 / 58140 (3.9%) | −46.8 | −45.0 | 0.19 |
| FOXA1 SRX6878604 | LNCAP Prostate | 111 / 5814 (1.9%) | 3454 / 58140 (5.9%) | −46.8 | −45.0 | 0.32 |
| WAS SRX5371248 | Lymphoblastoid cell line Blood | 329 / 5814 (5.7%) | 1241 / 58140 (2.1%) | −46.8 | −45.0 | 2.65 |
| ESR1 SRX371469 | MCF-7 Breast | 154 / 5814 (2.6%) | 4135 / 58140 (7.1%) | −46.8 | −44.9 | 0.37 |
| CDT1 SRX10644243 | HCT 116 Digestive tract | 556 / 5814 (9.6%) | 2748 / 58140 (4.7%) | −46.7 | −44.8 | 2.02 |
| BRD4 SRX23813262 | C4-2B Prostate | 536 / 5814 (9.2%) | 2610 / 58140 (4.5%) | −46.6 | −44.8 | 2.05 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 129 / 5814 (2.2%) | 3736 / 58140 (6.4%) | −46.6 | −44.8 | 0.35 |
| HIF1A SRX8180621 | Peripheral blood mononuclear cells Blood | 72 / 5814 (1.2%) | 39 / 58140 (0.1%) | −46.6 | −44.7 | 18.46 |
| FOXA1 SRX5203307 | MCF-7 Breast | 36 / 5814 (0.6%) | 2087 / 58140 (3.6%) | −46.5 | −44.7 | 0.17 |
| TEAD1 SRX7807114 | Unclassified Unclassified | 71 / 5814 (1.2%) | 2762 / 58140 (4.8%) | −46.5 | −44.7 | 0.26 |
| FOXA1 SRX3923517 | MCF-7 Breast | 94 / 5814 (1.6%) | 3161 / 58140 (5.4%) | −46.5 | −44.7 | 0.30 |
| SUPT6H SRX15147167 | DLD-1 Digestive tract | 452 / 5814 (7.8%) | 2033 / 58140 (3.5%) | −46.5 | −44.7 | 2.22 |
| FOXA1 SRX667986 | VCaP Prostate | 77 / 5814 (1.3%) | 2865 / 58140 (4.9%) | −46.5 | −44.7 | 0.27 |
| FOXA1 SRX3923518 | MCF-7 Breast | 91 / 5814 (1.6%) | 3109 / 58140 (5.3%) | −46.5 | −44.6 | 0.29 |
| HDAC1 SRX17989501 | PBMC Blood | 688 / 5814 (11.8%) | 3717 / 58140 (6.4%) | −46.5 | −44.6 | 1.85 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 141 / 5814 (2.4%) | 3916 / 58140 (6.7%) | −46.3 | −44.5 | 0.36 |
| RELA SRX7054664 | HAEC Cardiovascular | 136 / 5814 (2.3%) | 3839 / 58140 (6.6%) | −46.3 | −44.5 | 0.35 |
| Epitope tags SRX667413 | MCF-7 Breast | 657 / 5814 (11.3%) | 3493 / 58140 (6.0%) | −46.2 | −44.4 | 1.88 |
| EP300 SRX1521303 | ZR-75-30 Breast | 101 / 5814 (1.7%) | 3270 / 58140 (5.6%) | −46.2 | −44.3 | 0.31 |
| RELA SRX7054670 | HAEC Cardiovascular | 149 / 5814 (2.6%) | 4032 / 58140 (6.9%) | −46.1 | −44.3 | 0.37 |
| Epitope tags SRX20570808 | Keratinocytes Epidermis | 302 / 5814 (5.2%) | 1090 / 58140 (1.9%) | −46.1 | −44.2 | 2.77 |
| CEBPB SRX1027437 | Mesenchymal stem cells Others | 84 / 5814 (1.4%) | 2973 / 58140 (5.1%) | −46.0 | −44.2 | 0.28 |
| TEAD4 SRX10640860 | SK-MEL-147 Epidermis | 196 / 5814 (3.4%) | 4739 / 58140 (8.2%) | −46.0 | −44.2 | 0.41 |
| SOX2 SRX1047416 | hESC derived neural cells Pluripotent stem cell | 78 / 5814 (1.3%) | 2867 / 58140 (4.9%) | −46.0 | −44.2 | 0.27 |
| Epitope tags SRX15426922 | Keratinocytes Epidermis | 245 / 5814 (4.2%) | 767 / 58140 (1.3%) | −46.0 | −44.2 | 3.19 |
Showing first 500 of 12819 rows.